Key result
Bioprosthetic aortic valve replacement showed similar 15-year survival compared to mechanical valves.
Why the study?
Does mechanical aortic valve replacement improve survival compared to bioprosthetic aortic valve replacement in patients aged 50-65 years with severe isolated aortic stenosis?
Cohort (n=200)
No
Does mechanical aortic valve replacement improve survival compared to bioprosthetic aortic valve replacement in patients aged 50-65 years with severe isolated aortic stenosis?
In patients aged 50-65 with severe aortic stenosis, mechanical and bioprosthetic valves showed similar 15-year survival, though mechanical valves trended toward higher rates of major bleeding and cardiovascular complications.
Answers are grounded in this paper and cite their sources.
No survival benefit for mechanical valves; should not change practice and leaves open need for randomized confirmation in this age group.
To investigate long term survival (15 years) and major morbidity in patients aged 50–65 years undergoing primary isolated aortic valve replacement with bioprosthetic or mechanical valves. A single center retrospective analytical study of all patients aged 50–65 years with severe aortic stenosis who underwent surgery between 2000 and 2015 was performed (n = 200). Two groups, mechanical (n = 117) and biological (n = 83) were obtained. Propensity score matching was performed for analysis. Primary outcome was survival, secondary outcome was major adverse cardiovascular complications (30-day mortality, stroke, any prosthesis-related reoperation and major bleeding). Mean age was 60 ± 4 years, 33% female, mean follow up was 8.2 ± 3 years (range 0–17 years). Matched overall survival was similar between groups, 65% at 15 years [Log Rank p = 0.71, hazard ratio 0.87 (95% CI, 0.41–1.82)]. After matching, mechanical prosthesis presented a trend toward of more major adverse cardiovascular complications (30% versus 15%, p = 0.07) with more major bleedings (15% versus 6.3%, p = 0.06), stroke 11% versus 7.6% (p = 0.44), and cardiac-related rehospitalization (33.7% versus 21.5%, p = 0.06). Reoperation was nonsignificant between groups (2.5% mechanical versus 6.3% bioprosthesis, with only 2 cases of structural valve degeneration). Follow up mean transprosthetic gradients were higher in the mechanical group (18 ± 6 versus 15 ± 7 mmHg, p = 0.01). Among propensity matched patients there were no differences in survival between groups at 15 years. The mechanical prosthesis presented a trend toward twofold more major adverse cardiovascular complications specially due to major bleeding. Studies with larger sample sizes are needed to confirm these results. Investigar la supervivencia a largo plazo (15 años) y la morbilidad en pacientes de 50 a 65 años sometidos a reemplazo valvular aórtico aislado con válvulas bioprotésicas o mecánicas. Estudio analítico retrospectivo unicéntrico, de pacientes de 50-65 años con estenosis aórtica severa que se sometieron a cirugía entre 2000-2015 (n = 200). Se obtuvieron 2 grupos, mecánico (n = 117) y biológico (n = 83). Se realiza puntuación de propensión para el análisis final. El objetivo primario fue la supervivencia a largo plazo y como objetivos secundarios las complicaciones cardiovasculares mayores (mortalidad a 30 días, ictus, reintervención protésica y hemorragia grave). La edad media fue 60 ± 4 años, un 33% mujeres. El seguimiento medio fue de 8,2 ± 3 años. La supervivencia global fue similar, del 65% a los 15 años (log rank p = 0,71, hazard ratio 0,87 [IC 95%: 0,41-1,82]). Después del pareado las prótesis mecánicas presentaron una tendencia hacia más complicaciones cardiovasculares mayores (30% vs 15%, p = 0,07) con más hemorragias mayores (15% vs 6,3% p = 0,06), ictus (11% vs 7,6%, p = 0,44) y rehospitalización de causa cardíaca (33,7% vs 21,5%, p = 0,06). La reintervención no fue significativa entre grupos (2,5% mecánicas vs 6,3% bioprótesis, 2 casos de degeneración valvular estructural). Los gradientes transprotésicos fueron mayores en el grupo mecánico (18 ± 6 vs 15 ± 7 mm Hg, p = 0,01). No hubo diferencias en la supervivencia a 15 años. Las prótesis mecánicas presentaron una tendencia al doble de complicaciones mayores, especialmente debido a sangrado mayor. Se necesitan estudios con mayor tamaño muestral para confirmar estos datos.
No takes yet. Share an insight, caveat, or question.
Rodríguez-Caulo et al. (2018) conducted a cohort in severe aortic stenosis (n=200). Bioprosthetic aortic valve replacement vs. Mechanical aortic valve replacement was evaluated on long term survival (15 years) (HR 0.87, 95% CI 0.41-1.82, p=0.71). Bioprosthetic aortic valve replacement showed similar 15-year survival compared to mechanical valves.
Synapse has enriched 10 related papers. Consider them for comparative context: